Impact of Maternal Postpartum Tetanus and Diphtheria Toxoids and Acellular Pertussis Immunization on Infant Pertussis Infection | Zendy

Luis A. Castagnini | Zendy; Catherine Healy | Zendy; Marcia A. Rench | Zendy; Susan H. Wootton | Zendy; Flor M. Muñoz | Zendy; Carol J. Baker | Zendy

Open Access

Impact of Maternal Postpartum Tetanus and Diphtheria Toxoids and Acellular Pertussis Immunization on Infant Pertussis Infection

Author(s) -

Luis A. Castagnini,

Catherine Healy,

Marcia A. Rench,

Susan H. Wootton,

Flor M. Muñoz,

Carol J. Baker

Publication year - 2011

Publication title -

clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cir765

Subject(s) - medicine , diphtheria , tetanus , pediatrics , population , odds ratio , immunization , pertussis vaccine , whooping cough , confidence interval , vaccination , immunology , antibody , environmental health

Mothers often are the source of pertussis illness in young infants. The Centers for Disease Control and Prevention recommend tetanus and diphtheria toxoids and acellular pertussis (Tdap) vaccine for postpartum women before hospital discharge. In January 2008, this recommendation was implemented in a predominantly Hispanic, medically underserved population at Ben Taub General Hospital (BTGH) in Houston (hereafter the intervention population).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research